TY - JOUR
T1 - Patient-Tailored Aortic Valve Replacement
AU - De Backer, Ole
AU - Wong, Ivan
AU - Wilkins, Ben
AU - Carranza, Christian Lildal
AU - Søndergaard, Lars
N1 - Copyright © 2021 De Backer, Wong, Wilkins, Carranza and Søndergaard.
PY - 2021
Y1 - 2021
N2 - Contemporary surgical and transcatheter aortic valve interventions offer effective therapy for a broad range of patients with severe symptomatic aortic valve disease. Both approaches have seen significant advances in recent years. Guidelines have previously emphasized 'surgical risk' in the decision between surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR), although this delineation becomes increasingly obsolete with more evidence on the effectiveness of TAVR in low surgical risk candidates. More importantly, decisions in tailoring aortic valve interventions should be patient-centered, accounting not only for operative risk, but also anatomy, lifetime management and specific co-morbidities. Aspects to be considered in a patient-tailored aortic valve intervention are discussed in this article.
AB - Contemporary surgical and transcatheter aortic valve interventions offer effective therapy for a broad range of patients with severe symptomatic aortic valve disease. Both approaches have seen significant advances in recent years. Guidelines have previously emphasized 'surgical risk' in the decision between surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR), although this delineation becomes increasingly obsolete with more evidence on the effectiveness of TAVR in low surgical risk candidates. More importantly, decisions in tailoring aortic valve interventions should be patient-centered, accounting not only for operative risk, but also anatomy, lifetime management and specific co-morbidities. Aspects to be considered in a patient-tailored aortic valve intervention are discussed in this article.
UR - http://www.scopus.com/inward/record.url?scp=85120462970&partnerID=8YFLogxK
U2 - 10.3389/fcvm.2021.658016
DO - 10.3389/fcvm.2021.658016
M3 - Review
C2 - 33969021
SN - 2297-055X
VL - 8
SP - 658016
JO - Frontiers in Cardiovascular Medicine
JF - Frontiers in Cardiovascular Medicine
M1 - 658016
ER -